Showing 3 posts of 3 posts found.

Merck image

Merck to test Keytruda combinations

May 8, 2015
Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab

Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011
Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

Roche’s melanoma candidate impresses in phase II trials

November 5, 2010
Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …

Latest content